HP
IPXL

Hound Partners’s Impax Laboratories, Inc. IPXL Stock Holding History

Hound Partners’s Portfolio IPXL Stock Details IPXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-4,436,376
Closed -$58.8M – 29
2016
Q4 		$58.8M Sell
4,436,376
-1,768,212
-28% -$30.2M 1.42% 21
2016
Q3 		$147M Sell
6,204,588
-552,970
-8% -$14.9M 3.96% 10
2016
Q2 		$195M Hold
6,757,558
– – 5.18% 8
2016
Q1 		$216M Sell
6,757,558
-222,708
-3% -$7.83M 5.88% 7
2015
Q4 		$298M Sell
6,980,266
-130,000
-2% -$5.19M 6.77% 7
2015
Q3 		$250M Buy
7,110,266
+1,497,918
+27% +$67.5M 5.41% 7
2015
Q2 		$258M Buy
5,612,348
+4,895,290
+683% +$232M 5.61% 8
2015
Q1 		$33.6M Buy
+717,058
New +$28.5M 0.74% 23

Other funds holding IPXL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NTC
North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

Hound Partners's IPXL Position: Q1 2017 in Review

Hound Partners sold out of Impax Laboratories, Inc. (IPXL) in Q1 2017, closing a stake of 4,436,376 shares — an estimated $58.8M sold.

Hound Partners first reported a position in IPXL in Q1 2015 and held it in 8 quarters. The position peaked at $298M in Q4 2015. 178 funds tracked by Wall St. Rank hold IPXL as of Q1 2017.

  • Hound Partners reported no remaining Impax Laboratories, Inc. position as of Q1 2017 after selling out during the quarter.
  • Hound Partners sold 4,436,376 Impax Laboratories, Inc. shares in Q1 2017, an estimated $58.8M.
  • Hound Partners first reported a position in Impax Laboratories, Inc. in Q1 2015 and held it in 8 quarters.
  • Hound Partners's Impax Laboratories, Inc. position peaked at $298M in Q4 2015.
  • 178 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q1 2017.

Based on Hound Partners's 13F filing for Q1 2017, filed 15 May 2017.